This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shahzad G. Raja Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raja, S. G. Articles by Fida, N. Search for Related Content PubMed PubMed Citation Articles by Raja, S. G. Articles by Fida, N. Related Collections Related Articles

Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?

Department of Cardiothoracic Surgery, Harefield Hospital, Hill End Road, Harefield, UB9 6JH, Middlesex, UK

*Corresponding author. Tel.: +44 1895 828665; fax: +44 1895 828666.

E-mail address: drrajashahzad{at}hotmail.com (S.G. Raja).

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the omission of angiotensin converting inhibitors (ACEI)/angiotensin II receptor antagonists (AIIA) before cardiac surgery leads to avoidance of postoperative vasodilation. Using the reported search 421 papers were identified. Eleven papers including three randomised controlled trials (RCTs) represented the best evidence on the subject. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study comments and weaknesses were tabulated for these. Whereas the three small RCTs on this topic provided conflicting evidence, the remaining seven large cohort and case-control studies confirmed that preoperative ACEI therapy resulted in postoperative low systemic vascular resistance (SVR)/vasoplegia. Only two small RCTs with conflicting conclusions specifically addressed the issue of omitting ACEI/AIIA before cardiac surgery. We conclude that preoperative administration of ACEI/AIIA in patients undergoing cardiac surgery contributes to lowering of SVR/vasoplegia postoperatively thereby making omission of ACEI/AIIA before cardiac surgery a rational strategy to avoid postoperative vasodilation. However, the current available evidence to support this strategy is weak.

Key Words: Angiotensin converting enzyme inhibitors; Angiotensin II receptor blockers; Systemic vascular resistance; Cardiac surgery; Evidence-based medicine

Related Articles

ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery

Karsten Knobloch, Andreas Gohritz, Marcus Spies, and Peter M. Vogt
Interactive CardioVascular and Thoracic Surgery 2008 7: 475-476. [Full Text] [PDF]

This article has been cited by other articles:

				A. Miceli, R. Capoun, C. Fino, P. Narayan, A. J. Bryan, G. D. Angelini, and M. Caputo Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1778 - 1784. [Abstract] [Full Text] [PDF]

				A. Noto, S. Lentini, A. Versaci, M. Giardina, D. C. Risitano, R. Messina, and A. David A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 588 - 592. [Abstract] [Full Text] [PDF]

				K. Knobloch, A. Gohritz, M. Spies, and P. M. Vogt ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 475 - 476. [Full Text] [PDF]

				S. G. Raja ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 476 - 476. [Full Text] [PDF]